about
Studying bacteria in respiratory specimens by using conventional and molecular microbiological approachesPrevention of viral induced asthma attacks using inhaled budesonide.Prednisolone and salbutamol in the hospital treatment of acute asthma.Diagnosis of cystic fibrosis: Indian perspective.Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.A quantitative analysis of Ureaplasma urealyticum and Ureaplasma parvum compared with host immune response in preterm neonates at risk of developing bronchopulmonary dysplasiaContributions of Composition and Interactions to Bacterial Respiration Are Reliant on the Phylogenetic Similarity of the Measured Community.Treating childhood asthma in Singapore: when West meets East.Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms.Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer.Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) InstrumentCystic Fibrosis Nutrition--Chewing the Fat.Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.Prolonged hypoxaemia after nebulised salbutamol.Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.Acute wheezy bronchitis--lumping and splitting.rhDNase in cystic fibrosis.Long term results of lung resection in cystic fibrosis patients with localised lung disease.Presence of domestic pets and respiratory symptoms in asthmatic children.A population-based study of fish allergy in the Philippines, Singapore and Thailand.Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis.Falsely elevated serum tobramycin levels in a patient receiving nebulised tobramycin.Somatizing disorders affecting the respiratory tract.Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial.Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosis.Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis.Manifesting carriage of a Duchenne muscular dystrophy mutation: an unusual cause of impaired lung function in CF.Inhaled budesonide and behavioural disturbancesVeno-venous haemodiafiltration in meningococcal septicaemiaFlexible fibre-optic bronchoscopy in the management of lung complications in cystic fibrosisBronchoscopic appearances of congenital lobar emphysemaEffects of an acaricide on asthmatic children with house dust mite allergyUse of pulse oximetry in the hospital management of acute asthma in childhoodFaecal elastase 1: a marker of exocrine pancreatic insufficiency in cystic fibrosisInflammatory pseudotumor of the trachea in a ten-month-old infantRespiratory illnesses are among the most common causes of morbidity and mortality during childhoodDiffuse microcystic pancreatic enlargement in a cystic fibrosis patient causing severe gastrointestinal symptoms and successfully treated by total pancreatectomyThe prevalence of stress urinary incontinence in patients with cystic fibrosis: an under-recognized problem
P50
Q33430526-03A1F264-A688-43F3-862C-EA6036299C5AQ33623046-9AA5DAAD-CD01-45E6-A660-9C3F03DA087AQ33624385-58E4B2FD-9767-452F-A157-ADF02F5AB19CQ33911040-6BA6E7F7-3947-41D5-8A96-8B95C6AC1A37Q34311087-B96BFF8A-7244-4F26-8394-8CCAC4790C40Q35807027-B253C7B6-565D-46DA-A528-4C2DCF3582B8Q36357456-8D4897F6-5811-40F4-9B7A-3BE58C289300Q36885518-75047312-0130-4434-BE44-B695259BDF54Q37612986-62DD0CFF-D50B-4947-9712-27F82870ED33Q37807456-B47AA53A-D6ED-4552-9CD3-F7E438D0C868Q38884731-67DF6DCF-41F0-45EA-AA65-F82E519E5550Q38947027-8819F87A-FF86-4D2B-B749-F15B45055573Q40116694-2BEE8DB8-8957-457F-9428-F115AD865E73Q41015058-9E272B89-A779-4DAD-B748-AE4BD8341115Q41150461-614A335A-B9C4-420F-AFA2-196DFD74196FQ41481789-3F5CCE25-07A5-4128-82D2-7A03084ADD52Q42964263-C0F97DD7-29B7-46AF-99FC-0ABCD5C64777Q43060831-66FD4B80-B809-410B-8245-42C3524B566AQ43100751-1A86B25A-04B2-4373-BDC0-2BFD0EC37208Q43209090-9B1B013F-1D52-47FA-82BE-64C14C186289Q44260600-25D454C4-E1E1-42CA-97E7-C169A4A1F497Q44906672-99704154-577B-4A28-AABB-D78E5446FBD3Q45088938-38F4BF0A-7EC4-4FAD-A97F-1F2C79109CEEQ47672165-5BA6CF30-FCB0-412A-A25D-A7FEEFE21B4AQ50795480-24D64BB4-FF00-4699-A63B-CE9AAE7F4BE3Q51348937-C5220AAB-7C86-4552-B2D8-522C05E4EB2AQ51673635-4AA191AC-06C9-4538-9A2F-790775CF295AQ53780013-DC979A84-BDEF-48F7-8DC2-BBB056EC7786Q54487655-B880571D-2CA8-49D9-ADDA-371B86D76609Q68313548-1051C9EA-CCED-4161-B7AE-8ACD45F48574Q70989200-360282CE-F47E-4474-B875-386A5C9C34AEQ71554923-191D4F47-77AC-42D5-B521-458B03D52BBBQ71660513-C4FA51D4-D09A-4DE2-AAB1-6EE9D934DD5CQ72581854-4EA20505-E952-4522-A01C-A4263A9EA2C6Q72845421-8CE5B676-FF8C-4049-9B24-BECD457D0EF7Q73245385-7C0B3E3E-1564-4C7D-880A-C10C57ACD36DQ73319236-2D0C2C60-55A7-4F5D-A204-E8085EB68D64Q73835931-6A4F758A-1795-44B3-8DE9-9D4C2D923A50Q74463981-4613CDF9-216D-43D0-A913-DA48567EB596Q79693849-2C663F0D-658D-47E7-ADFD-342EA648C847
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gary Connett
@ast
Gary Connett
@en
Gary Connett
@es
Gary Connett
@nl
type
label
Gary Connett
@ast
Gary Connett
@en
Gary Connett
@es
Gary Connett
@nl
prefLabel
Gary Connett
@ast
Gary Connett
@en
Gary Connett
@es
Gary Connett
@nl
P106
P31
P496
0000-0003-1310-3239